ENVUE MEDICAL INC
FEEDNASDAQ🏆 #3992 by market capUS Equity
$951.08▲ $31.10 (+3.27%)
Simulated price1h—
24h▲ 3.3%
7d▲ 256948.6%
14d▲ 281035.1%
30d▲ 208287.4%
1y▲ 12632.0%
🏦Market Cap
$4M
Small Cap
📈Revenue Growth (YoY)
—
📊Gross Margin
-12.4%
Thin
💵FCF Margin
—
⚖️P/S Ratio
1.6x
Cheap
Otter Score
58
Weak
Trading Snapshot
- Day Range
- $939.44 – $963.07
- 52-Week Range
- $0.29 – $17.40
- Volume
- $2.64B
- Avg Volume
- $2.53B
- Shares Outstanding
- 8.7M
- Next Earnings
- Sep 11, 2026
Fundamentals Snapshot
- Annual Revenue
- $2M
- Last Q Revenue
- $599,333
- P/E Ratio
- —
- P/S Ratio
- 1.6x
- EPS (TTM)
- $-20.43
- Dividend Yield
- —
Why Investors Own FEED
- ✓High-growth profile — revenue up +14.3% YoY with expanding US Equity exposure.
- ✓Healthy economics — 47% gross margin and 18% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
⚠️ Key Risks
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
Revenue (TTM)
$2M▲ +12.8% YoY
Gross Margin (TTM)
47.4%▲ +4.5% YoY
Operating Income (TTM)
$730,098▲ +12.8% YoY
Free Cash Flow (TTM)
$395,376▲ +12.8% YoY
About ENVUE MEDICAL INC
A company profile for ENVUE MEDICAL INC isn’t available yet — check back soon.
🦦
Otter Score Breakdown
ⓘ💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
⚡Momentum★★★★★
Overall Score
Weak
58/100
Analyst Price Target
ⓘAverage Target
$1,033.18
▲ +8.6% Upside
High Target$1,256.20
Low Target$954.64
Based on 17 analysts
Latest News & Updates
🚀
Barron’s·2h ago
ENVUE MEDICAL INC tops quarterly estimates as demand accelerates
Revenue grew double digits with management guiding above consensus; margins continued to expand.
🛰️
CNBC·5h ago
Analysts lift FEED price targets on improving margins
Several firms raised targets, citing stronger free cash flow and a healthier backlog.
🌌
Barron’s·1d ago
ENVUE MEDICAL INC announces new agreement to expand its footprint
The move broadens the company’s reach and could add incremental revenue over the next year.